That may be but if DCVax-L had those kinds of sales I think it is a virtual certainty that YOU and every short here would label it a “bust”. Meanwhile the long you replied to said the opposite, that Gilead paid $21B for it.
Shorts play all sides of every argument to always argue, maximally, that longs are “delusional”, that other drugs are better, regardless of the details, and that DCVax-L is a bust, again, regardless of details.
So yeah, if DCVax-L generated those levels of sales, I am pretty certain shorts would be on here day and night saying, “it’s a bust”!!! What else would they or could they do?